首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   1190篇
  免费   129篇
  国内免费   3篇
耳鼻咽喉   14篇
儿科学   104篇
妇产科学   31篇
基础医学   290篇
口腔科学   20篇
临床医学   116篇
内科学   211篇
皮肤病学   13篇
神经病学   30篇
特种医学   81篇
外科学   114篇
综合类   16篇
预防医学   48篇
眼科学   60篇
药学   76篇
肿瘤学   98篇
  2023年   6篇
  2022年   5篇
  2021年   29篇
  2020年   19篇
  2019年   23篇
  2018年   27篇
  2017年   23篇
  2016年   21篇
  2015年   31篇
  2014年   29篇
  2013年   33篇
  2012年   39篇
  2011年   48篇
  2010年   34篇
  2009年   39篇
  2008年   40篇
  2007年   44篇
  2006年   48篇
  2005年   46篇
  2004年   29篇
  2003年   34篇
  2002年   36篇
  2001年   44篇
  2000年   29篇
  1999年   33篇
  1998年   37篇
  1997年   44篇
  1996年   49篇
  1995年   33篇
  1994年   44篇
  1993年   20篇
  1992年   41篇
  1991年   47篇
  1990年   33篇
  1989年   26篇
  1988年   28篇
  1987年   20篇
  1986年   11篇
  1985年   16篇
  1984年   5篇
  1983年   13篇
  1982年   10篇
  1981年   6篇
  1980年   12篇
  1979年   7篇
  1977年   3篇
  1976年   6篇
  1974年   4篇
  1972年   4篇
  1970年   2篇
排序方式: 共有1322条查询结果,搜索用时 15 毫秒
1.
2.
3.
Benign intracranial hypertension (BIH) is reported in three children from Australia and one from New Zealand, who were being treated with recombinant human growth hormone (rhGH). Three males and one female, aged between 10.5 and 14.2 y, developed intracranial hypertension within 2 weeks to 3 months of starting treatment. A national database, OZGROW, has been prospectively collecting data on all 3332 children treated with rhGH in Australia and New Zealand from January 1986 to 1996. The incidence of BIH in children treated with growth hormone (GH) is small, 1.2 per 1000 cases overall, but appears to be greater with biochemical GHD (<10IUml -1), i.e. 6.5/1000 (3 in 465 cases), relative risk 18.4, 95% confidence interval 1.9-176.1, than in all other children on the database. The incidence in patients with Turner's syndrome was 2.3/1000 (1 in 428 cases). No cases in patients with partial GHD (10–20 IUml -1) or chronic renal failure were identified. Possible causative mechanisms are discussed. The authors'practice is now to start GH replacement at less than the usual recommended dose of 14IUm-2 week-1 in those children considered to be at high risk of developing BIH. Ophthalmological evaluation is recommended for children before and during the first few months following commencement of rhGH therapy and is mandatory in the event of peripheral or facial oedema, persistent headaches, vomiting or visual symptoms. The absence of papilledema does not exclude the diagnosis.  相似文献   
4.
Intensity-modulated radiation therapy (IMRT) is commonly delivered using the dynamic or segmental mode of multileaf collimators (DMLC or SMLC). Both methods are designed to deliver intensity-modulated beams as determined by inverse planning software. In this study, we have used the Helios IMRT planning system to generate ideal treatment plans for 10 cases of 2 common treatment sites (prostate and head and neck) and have investigated the actual treatment fluence distributions generated for each of the MLC leaf motion choices. The 2 dose delivery techniques were dosimetrically compared to each other and to the treatment plans. For each technique, point doses were measured in a water phantom using ionization chambers. Also for each technique, 2-dimensional dose distributions at a selected depth in a plastic phantom were obtained, using extended range film. The total delivery time and the number of monitor units (MU) delivered by each method were also compared. Our results indicate that the 2 delivery methods produce comparable results dosimetrically. For the cases reviewed, the delivery time was an average of 15% longer for SMLC deliveries, while the number of MUs (beam-on time) required by SMLC was an average of 15% fewer, than that for the DMLC. In the interest of simplicity, lower beam-on time, and potentially fewer mechanically-related problems, we think that the SMLC delivery technique may be the better choice when Helios is used for planning and Varian linear accelerators are used for delivery.  相似文献   
5.
6.
7.
8.
9.
"Nonspecific" electrolytic lesions (with respect to subdivision) of the mouse inferior colliculus (IC) resulted in the attenuation of acoustic startle response (ASR) amplitudes on the 1st post-operative day, but ASR amplitudes increased to above baseline levels 1 week later. Lesions of the IC central nucleus (CN) also attenuated ASR amplitudes on the 1st postsurgery day, but startle amplitudes recovered to baseline levels 1 week after surgery. Lesions of the IC lateral nucleus (LN) or dorsal cortex (DC) resulted in elevation of startle amplitudes above baseline 7 days after surgery and produced enhanced ASR amplitudes to repeated stimuli. Fourteen days after the surgery, lesion effects on startle amplitudes remained the same as those on Day 7 for each lesion condition. The present findings implicate the ICLN and the ICDC as inhibitory modulators of the ASR, but indicate only a minor role for the ICCN.  相似文献   
10.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号